Skip to main content
. Author manuscript; available in PMC: 2023 Nov 1.
Published in final edited form as: J Am Coll Clin Pharm. 2022 Aug 27;5(11):1161–1175. doi: 10.1002/jac5.1699

Figure 5.

Figure 5.

Clinical Decision Making Process for Pharmacogenetic Testing The clinical workflow should ideally integrate 4 elements to support a successful implementation: 1) patient identification; 2) pharmacogenetic test ordering; 3) interpretation and application of test results (e.g., drug therapy changes); and 4) patient education

This figure has been reprinted with permission from Weitzel KW, Duong BQ, Arwood MJ, Owusu-Obeng A, Abul-Husn NS, Bernhardt BA, Decker B, Denny JC, Dietrich E, Gums J, Madden EB, Pollin TI, Wu RR, Haga SB, Horowitz CR. A stepwise approach to implementing pharmacogenetic testing in the primary care setting. Pharmacogenomics. 2019 Oct;20(15):1103–1112.